EU watchdog backs Novavax COVID-19 vaccine


The Hague – Europe’s medicines watchdog on Monday approved a COVID-19 jab by US-based Novavax, which uses a more conventional technology that the biotech firm hopes will reduce vaccine hesitancy.

“EMA has recommended granting a conditional marketing authorization for Novavax’s COVID-19 vaccine Nuvaxovid to prevent COVID-19 in people from 18 years of age,” the European Medicines Agency said of the jab, the fifth to be recommended for authorization in the European Union.


You may also like

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: